Rheumatology
3 orthopedic surgeries that might be doing patients (and their pockets) more harm than good.
25 Mar, 2022 | 09:54h | UTC
Biomarkers may be an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica.
24 Mar, 2022 | 08:17h | UTCCommentary: Biomarkers may improve giant cell arteritis diagnosis – medwireNews
Commentary on Twitter
In our newest paper we investigated biomarkers that aid the diagnosis of Giant Cell Arteritis versus PMR or other mimicing conditions. This time, we worked together with our colleagues in Aarhus, Denmark to measure the biomarkers in 2 independent cohortshttps://t.co/d6PWsGSl2H
— Yannick van Sleen (@SleenYannick) March 11, 2022
Inflammatory eye disease: An overview of clinical presentation and management.
24 Mar, 2022 | 08:07h | UTC
An update on the clinical approach to giant cell arteritis.
24 Mar, 2022 | 08:03h | UTCAn update on the clinical approach to giant cell arteritis – Clinical Medicine Journal
Phase 2 trial of Iberdomide in systemic lupus erythematosus.
22 Mar, 2022 | 08:27h | UTCPhase 2 Trial of Iberdomide in Systemic Lupus Erythematosus – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Mixed Results for Oral Lupus Drug in Phase II— Mid-stage study offers hope but also reason for caution – MedPage Today (free registration required)
Commentary on Twitter
In patients with systemic lupus erythematosus, iberdomide at the highest dose, but not at lower doses, was superior to placebo with respect to the primary end point of an SRI-4 response at 24 weeks. https://t.co/rie3SRhoew pic.twitter.com/wRre5Gp1xB
— NEJM (@NEJM) March 17, 2022
M-A: Rheumatoid arthritis in spine surgery.
21 Mar, 2022 | 08:19h | UTCRheumatoid Arthritis in Spine Surgery: A Systematic Review and Meta-Analysis – Global Spine Journal
Cohort Study: Association between long-term exposure to air pollution and immune-mediated diseases.
17 Mar, 2022 | 08:40h | UTCNews Release: Long term exposure to air pollution linked to heightened autoimmune disease risk – BMJ Newsroom
Commentaries:
Air pollution linked to higher risk of autoimmune diseases – The Guardian
Breathing Dirty Air Could Raise Your Odds for Rheumatoid Arthritis – HealthDay
Cohort Study: TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area.
16 Mar, 2022 | 08:44h | UTC
Review | Resistance exercise as a treatment for sarcopenia: prescription and delivery.
15 Mar, 2022 | 09:55h | UTCResistance exercise as a treatment for sarcopenia: prescription and delivery – Age and Ageing
Updated guideline summary introduces new recommendations for use of medications around total hip and knee replacement.
10 Mar, 2022 | 10:45h | UTCGuideline Summary (full guideline not available yet): 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty – American College of Rheumatology
RCT: Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis.
10 Mar, 2022 | 10:27h | UTCComparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial – The Lancet Rheumatology (link to abstract – $ for full-text)
Commentary: COMPLETE-PsA: Adding leflunomide to methotrexate may improve outcomes – medwireNews
Commentary on Twitter
NEW RESEARCH—A double-blind, placebo-controlled, randomised, trial comparing #methotrexate monotherapy with methotrexate plus #leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA) https://t.co/Fln7RlNl36 #LancetRheumatology pic.twitter.com/EqWSeHZQA2
— The Lancet Rheumatology (@TheLancetRheum) March 3, 2022
ACR/Vasculitis Foundation Guideline for the management of Kawasaki Disease.
9 Mar, 2022 | 10:01h | UTC
Bisphosphonate nephropathy: A case series and review of the literature.
9 Mar, 2022 | 08:32h | UTC
Guideline for perioperative management of patients with inflammatory rheumatic diseases.
8 Mar, 2022 | 08:43h | UTC
M-A: Efficacy of covid-19 vaccines in immunocompromised patients.
4 Mar, 2022 | 10:01h | UTCNews Release: Study suggests additional covid-19 vaccine doses for immunocompromised patients – BMJ Newsroom
Related: Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
Commentary on Twitter
NEW RESEARCH: Additional doses of covid-19 vaccine are recommended for immunocompromised patients, especially for organ transplant recipients who are least able to make antibodies to fight off coronavirus, suggests new research https://t.co/l2IWfSb0zd @sundar__raghav
— The BMJ (@bmj_latest) March 3, 2022
ACR Guidelines for the Treatment of Juvenile Idiopathic Arthritis.
4 Mar, 2022 | 08:58h | UTC
COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations.
3 Mar, 2022 | 08:46h | UTC
Commentary on Twitter
Our latest #Review is online now. #COVID-19 risks, outcomes and treatment considerations in #rheumatic disease.
Read it for #free here: https://t.co/WsmuyoFNGT@philipcrobinson pic.twitter.com/I4RWh0Gftr
— NatRevRheumatol (@NatRevRheumatol) February 28, 2022
Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019.
3 Mar, 2022 | 08:27h | UTCNews Release: Study reveals a persistently high burden of osteoarthritis across the globe – Wiley
A low-energy diet shows promise for reducing the symptoms of fibromyalgia.
3 Mar, 2022 | 08:23h | UTCEarly Relationships of a Low-Energy Diet With Symptoms of Fibromyalgia ACR Open Rheumatology
Commentary: Fibromyalgia Patients See Rapid Benefit From Low-Cal Diet — With marked symptom reduction in just 3 weeks, weight loss not a factor – MedPage Today (free registration required)
Erosive hand osteoarthritis: latest findings and outlook.
3 Mar, 2022 | 08:01h | UTCErosive hand osteoarthritis: latest findings and outlook – Nature Reviews Rheumatology (if the link is paywalled, try this one)
Commentary on Twitter
#MarchIssue | Read our #Review on the clinical features and risk factors of erosive hand #osteoarthritis (an aggressive condition with poor outcomes), and progress in biomarkers, imaging, classification and treatmenthttps://t.co/GSvgnXYYPS pic.twitter.com/PSzeucO0cH
— NatRevRheumatol (@NatRevRheumatol) February 28, 2022
Guideline: Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis.
27 Feb, 2022 | 22:40h | UTC
Commentary on Twitter
New rapid recommendation makes a weak recommendation against plasma exchange in patients with low risk of end stage kidney disease, and a weak recommendation in favour of plasma exchange in patients with moderate-high risk of ESKD https://t.co/PeEjSuRIxI #BMJInfographic pic.twitter.com/YR55t6XYhS
— The BMJ (@bmj_latest) February 25, 2022
M-A: Fetal and maternal outcomes after maternal biologic use during conception and pregnancy.
25 Feb, 2022 | 10:43h | UTC
Anti-inflammatory treatment of Kawasaki Disease: comparison of current guidelines and perspectives.
25 Feb, 2022 | 10:29h | UTC
RCT: Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine.
24 Feb, 2022 | 10:20h | UTCCommentary: Suspend Methotrexate for RA Patients Getting COVID Vax?— It’s not a simple choice, Brazilian study suggests (free registration required)
New practical aspects of Sweet Syndrome.
23 Feb, 2022 | 09:56h | UTCNew Practical Aspects of Sweet Syndrome – American Journal of Clinical Dermatology